✦ LIBER ✦

Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: External validation in a phase III trial comparing vinflunine with docetaxel

✍ Scribed by Di Maio, Massimo; Krzakowski, Maciej; Fougeray, Ronan; Kowalski, Dariusz M.; Gridelli, Cesare

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III trial comparing paclitaxel pol

✍ Paz-Ares, L; Ross, H; O'Brien, M; Riviere, A; Gatzemeier, U; Von Pawel, J; Kauke 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

Phase I study of second-line chemotherap

✍ Mikio Oka; Minoru Fukuda; Seiji Nagashima; Masaaki Fukuda; Akitoshi Kinoshita; H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 84 KB

O-1 A phase III trial comparing weekly a

✍ Schuette, Wolfgang; Nagel, Sylke; Lautenschlaeger, C.; Serke, Monika; Wollschlae 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Phase III trial of docetaxel (D) and car

✍ Giannakakis, Th; Mavroudis, D; Papadouris, S; Kourousis, Ch; Ziras, N; Kakolyris 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 224 KB

O-2 TWO second-line docetaxel dose-sched

✍ Camps, Carlos; Massuti, Bartomeu; Jimenez, Ana Maria; Batista, Noberto; Galan, A 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Second-Line Chemotherapy with a Modified

✍ Carmelo Tibaldi; Ilaria Bernardini; Antonio Chella; Francesa Russo; Enrico Vasil 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 134 KB